These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 30695571)
1. [Growth disorders after treatment for acute lymphoblastic leukemia in childhood]. Tselovalnikova TY; Pavlova MG; Zilov AV; Mazerkina NA; Zheludkova OG; Arefyeva IA; Gerasimov AN Vopr Onkol; 2016; 62(6):817-821. PubMed ID: 30695571 [TBL] [Abstract][Full Text] [Related]
2. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia. Vilela MI; Viana MB Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045 [TBL] [Abstract][Full Text] [Related]
4. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Sklar CA; Mertens AC; Walter A; Mitchell D; Nesbit ME; O'Leary M; Hutchinson R; Meadows AT; Robison LL Med Pediatr Oncol; 2000 Aug; 35(2):91-5. PubMed ID: 10918229 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. Oeffinger KC; Adams-Huet B; Victor RG; Church TS; Snell PG; Dunn AL; Eshelman-Kent DA; Ross R; Janiszewski PM; Turoff AJ; Brooks S; Vega GL J Clin Oncol; 2009 Aug; 27(22):3698-704. PubMed ID: 19564534 [TBL] [Abstract][Full Text] [Related]
6. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy. Touyz LM; Cohen J; Neville KA; Wakefield CE; Garnett SP; Mallitt KA; Grech AM; Cohn RJ Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27862918 [TBL] [Abstract][Full Text] [Related]
7. Height deficit and impairment of the GH/IGF-1 axis in patients treated for acute lymphoblastic leukemia during childhood. Vilela MI; Serravite Mde O; Oliveira NB; de Brito PC; Ribeiro-Oliveira A; Viana MB Horm Res Paediatr; 2013; 79(1):9-16. PubMed ID: 23306635 [TBL] [Abstract][Full Text] [Related]
8. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. Katz JA; Pollock BH; Jacaruso D; Morad A J Pediatr; 1993 Oct; 123(4):546-52. PubMed ID: 8410505 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors. Hata M; Ogino I; Aida N; Saito K; Omura M; Kigasawa H; Toyoda Y; Tachibana K; Matsubara S; Inoue T Int J Cancer; 2001; 96 Suppl():117-24. PubMed ID: 11992395 [TBL] [Abstract][Full Text] [Related]
12. Growth patterns and final height of survivors of childhood leukemia. Jaruratanasirikul S; Owasith K; Wongchanchailert M; Laosombat V; Sriplung H J Pediatr Endocrinol Metab; 2004 May; 17(5):719-26. PubMed ID: 15237705 [TBL] [Abstract][Full Text] [Related]
13. Final height and weight of long-term survivors of childhood malignancies. Müller HL; Klinkhammer-Schalke M; Kühl J Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation. Vandecruys E; Dhooge C; Craen M; Benoit Y; De Schepper J J Pediatr; 2013 Jul; 163(1):268-73. PubMed ID: 23351599 [TBL] [Abstract][Full Text] [Related]
15. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Birkebaek NH; Clausen N Arch Dis Child; 1998 Aug; 79(2):161-4. PubMed ID: 9797600 [TBL] [Abstract][Full Text] [Related]
16. Influence of treatment modalities on prepubertal growth in children with acute lymphoblastic leukemia. Groot-Loonen JJ; Otten BJ; van't Hof MA; Lippens RJ; Stoelinga GB Pediatr Hematol Oncol; 1995; 12(4):343-53. PubMed ID: 7577386 [TBL] [Abstract][Full Text] [Related]
17. Final height and puberty in 40 patients after antileukaemic treatment during childhood. Mohnike K; Dörffel W; Timme J; Kluba U; Aumann V; Vorwerk P; Mittler U Eur J Pediatr; 1997 Apr; 156(4):272-6. PubMed ID: 9128810 [TBL] [Abstract][Full Text] [Related]
18. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. Trimis G; Moschovi M; Papassotiriou I; Chrousos G; Tzortzatou-Stathopoulou F J Pediatr Hematol Oncol; 2007 May; 29(5):309-14. PubMed ID: 17483708 [TBL] [Abstract][Full Text] [Related]
19. Analysis of growth failure in children treated for acute lymphoblastic leukemia. Sato J; Ninomiya T; Tsuda Y; Komazawa M; Nagata K; Iwai A; Nishikawa K; Maeda H; Ohmiya A; Ohta M Int J Hematol; 1992 Dec; 56(3):205-12. PubMed ID: 1477332 [TBL] [Abstract][Full Text] [Related]
20. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]